The lab of Ian Shih, PhD, received the top prize from the journal NeuroImage for brain research featuring fMRI and fast-scan cyclic voltammetry. First author was Lindsay Walton, PhD.
Senyenne Hunter, MD, PhD, is one of two recipients who are the first grantees to receive the award.
William J. Powers, MD, Professor of Neurology and former department chair (April 2007 – April 2018) to retire on June 30.
UNC School of Medicine researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.
James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.
Dr. Senyene Hunter, assistant professor of child neurology, was named as a UNC School of Medicine Simmons Scholar, effective July 2022.
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
Monica Diaz, MD, MS, and Ana Felix, MBBCH, FAAN, have been elected as the 2022-2023 Vice Chairs of the American Academy of Neurology’s Global Health Section and the AB Baker Section for Neurological Education, respectively.
NC TraCS awarded funding for a $5K-$50K grant application submitted by Rebecca Traub, MD and Xiaoyan Li, MD, PhD.
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
